-
Mashup Score: 0For Detection of Measurable Residual Disease in Ovarian Cancer, Are Two Methods Better Than One? - 2 hour(s) ago
In patients with ovarian cancer, second-look surgery may find a role again. The evaluation of measurable residual disease (MRD) using second-look laparoscopy identified more women who had detectable M…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Hemihepatectomy: Outcomes With Laparoscopic vs Open Surgery - 4 hour(s) ago
In a phase III study, investigators found that among patients with indications for hemihepatectomy suitable for both laparoscopic and open approaches, of whom the majority had cancer, the laparoscopic…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Breast-Conserving Therapy in BRCA-Mutation Carriers: Study Looks at Long-Term Outcomes - 17 hour(s) ago
Recent research has provided valuable insights into the long-term outcomes of patients with pathogenic BRCA1 and BRCA2 mutations who undergo breast-conserving therapy, according to a study presented a…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Durvalumab After Chemoradiotherapy in Unresectable NSCLC: Real-World Use and Outcomes - 22 hour(s) ago
In a retrospective cohort study (SPOTLIGHT), investigators found that a substantial proportion of patients with unresectable stage III NSCLC did not receive consolidation durvalumab after chemoradioth…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Dato-DXd in Advanced or Metastatic HR-Positive/HER2-Negative or Triple-Negative Breast Cancer - 23 hour(s) ago
Results from the phase I TROPION-PanTumor01 trial showed that the antibody-drug conjugate datopotamab deruxtecan was active in patients with locally advanced or metastatic hormone receptor (HR)-positi…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
In a research letter, staff from Royal Brompton Hospital, Guy’s and St. Thomas’ NHS Foundation Trust in London described their experience over 10 years in the UK’s first cardio-oncology service.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Testing for measurable residual disease (MRD) prior to bone marrow transplant may be effective and practical in patients in remission after receiving treatment for AML, according to a recent study.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Breast-Conserving Therapy in BRCA-Mutation Carriers: Study Looks at Long-Term Outcomes - 1 day(s) ago
Recent research has provided valuable insights into the long-term outcomes of patients with pathogenic BRCA1 and BRCA2 mutations who undergo breast-conserving therapy, according to a study presented a…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
A novel AI model may accurately predict which patients with cancer may require mental health services during cancer care, according to results from a recent retrospective prognostic study.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
Monotherapy with the oral KRAS G12C inhibitor glecirasib demonstrated efficacy in previously treated patients with KRAS G12C–mutated NSCLC, according to data presented during the ASCO Plenary Series: …
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
For Detection of Measurable Residual Disease in Ovarian Cancer, Are Two Methods Better Than One? https://t.co/KAjLRdVmdU #gyncsm #ovariancancer #oncology #SGO2024 #SGO24 @SGO_org